Lonza unveils new business structure; expects to post above-market growth to 2023

10:52 AM | October 15, 2020 | Sotirios Frantzanas

New structure for its pharma, biotech, and nutrition segment will be operational 1 January 2021, in line with decision to divest its specialty ingredients segment.